Stocksigma LogoStocksigma Logo

Gland Pharma Approves USD 21 Million Investment in US Expansion

Gland Pharma鈥檚 Board approved an investment of USD 21m in its wholly-owned subsidiary, Gland Pharma USA Inc., on 1st Oct'26 to acquire a 60% stake in newly

Gland Pharma Approves USD 21 Million Investment in US Expansion

Gland Pharma Ltd 路 Others (Uncategorized) 路 01 Oct 2026, 9:21 pm

Gland Pharma Approves USD 21 Million Investment in US Expansion Gland Pharma鈥檚 Board approved an investment of USD 21m in its wholly-owned subsidiary, Gland Pharma USA Inc., on 1st Oct'26 to acquire a 60% stake in newly incorporated Novelstar Pharma Inc. for USD 21m in cash by 31st Oct'26, expanding its US business. Fosun Pharma USA Inc. will hold the remaining 40%. Additionally, Wenjie Zhang resigned as Non-Executive Director effective 1st Oct'26, and Xingli Wang was appointed as Additional Non-Executive Director.

Original exchange filing (PDF)

More announcements from Gland Pharma Ltd

All Gland Pharma Ltd announcements